Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.15 - $3.34 $21,807 - $63,336
-18,963 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.96 - $7.76 $3,306 - $8,667
-1,117 Reduced 5.56%
18,963 $58,000
Q4 2021

Feb 14, 2022

BUY
$7.4 - $11.66 $13,112 - $20,661
1,772 Added 9.68%
20,080 $149,000
Q3 2021

Nov 15, 2021

SELL
$9.18 - $14.15 $8,803 - $13,569
-959 Reduced 4.98%
18,308 $211,000
Q2 2021

Aug 10, 2021

SELL
$8.07 - $12.52 $146,260 - $226,912
-18,124 Reduced 48.47%
19,267 $241,000
Q1 2021

May 17, 2021

BUY
$8.57 - $15.79 $5,587 - $10,295
652 Added 1.77%
37,391 $387,000
Q4 2020

Feb 12, 2021

SELL
$5.98 - $12.47 $26,664 - $55,603
-4,459 Reduced 10.82%
36,739 $306,000
Q3 2020

Nov 13, 2020

SELL
$4.65 - $8.73 $26,216 - $49,219
-5,638 Reduced 12.04%
41,198 $254,000
Q2 2020

Aug 05, 2020

BUY
$4.66 - $8.7 $55,416 - $103,460
11,892 Added 34.03%
46,836 $390,000
Q1 2020

May 14, 2020

SELL
$5.05 - $15.01 $25,749 - $76,535
-5,099 Reduced 12.73%
34,944 $211,000
Q4 2019

Feb 13, 2020

BUY
$6.32 - $19.66 $253,071 - $787,245
40,043 New
40,043 $556,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $561M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.